Upcoming Event: The 3rd Asia Pharma R&D Innovation Conference 2019
10/30/2018
Event: The 3rd Asia Pharma R&D Innovation Conference 2019
Dates: March 13 - 14, 2019
Venue: Wyndham Bund East Shanghai, China
Weblink: www.aprdic.com
Contact: Marketing Department
Tel: +86 21 3160 2153
Email: Marketing@wbfgroup.com
Asia Pharma R&D Innovation 2019 is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CROs, academic institutions, technology and solution provider, investors and all the way down to other industrial stakeholders to assess the latest industrial trends, R&D strategies, partnership models and technology advancements in China and Asia.
This is the largest annual pharmaceutical R&D gathering in China featuring multiple conferences, summits and seminars that cover the entire value chain of the pharma R&D. Asia Pharma R&D Innovation 2019 will show you how you can access the important markets in Asia that matters most to your R&D strategies. Our aim is to promote global and regional deal making between pharmas, biotechs and academics in China and across other Asian countries and to leverage technologies to your advantage in promising drug discovery, screening, safety, clinical trials and R&D activities in the region.
Key topics will cover:
· Asia’s R&D landscape from big pharma’s eyes
· How Collaboration is Driving Innovation in Research & Development?
· Boosting China's new Drug Research and Development to Enhance Global Competitiveness
· Regulatory Data Protection, Patent Linkage and Patent Term Extension in New Drug Discovery and Development
· Tapping into Funding and Investment Opportunities on New Drug Discovery and Development in China
· Chinese BioPharma R&D Collaboration Opportunities and Development Models
· Innovation in the Future
· Case study of drug R&D and Oncology Therapeutic Focus
· Excellence in services – Technology showcase
· Omics, New Biomarker Discovery and Precision Medicine Development, Novel Technologies for Drug Discovery
· Clinical Trials Innovation
· Biomarker & Real World Data Based Decision Making in Drug Development
· Flexible and Efficient Data Management and Statistical Analysis
· Model-Driven Combined Design in Phase I/II Clinical Trials